Advertisement

Topics

ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients when combined with rituximab

07:33 EST 12 Dec 2017 | ecancermedicalscience

In a Phase III trial, treatment with the targeted cancer drug venetoclax in combination with rituximab more than doubled the likelihood that patients with chronic lymphocytic leukaemia (CLL) would survive for two years without cancer progression compared...

Original Article: ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients when combined with rituximab

NEXT ARTICLE

More From BioPortfolio on "ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients when combined with rituximab"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...